Tennessee Onc., PLLC - SCRI — Nashville, Tennessee

Tennessee Onc., PLLC - SCRI is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Tennessee Onc., PLLC - SCRI has participated in 4 clinical trials.

Therapeutic areas: Colorectal Cancer, Breast Cancer, Diffuse Large B-Cell Lymphoma.

Sponsors: Genentech, Inc., Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Onc., PLLC - SCRI?

Tennessee Onc., PLLC - SCRI has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Onc., PLLC - SCRI conducted?

Tennessee Onc., PLLC - SCRI has 4 clinical trials on record. Their work covers Colorectal Cancer, Breast Cancer, Diffuse Large B-Cell Lymphoma.

Is Tennessee Onc., PLLC - SCRI accredited by Crixeo Clinical Trials?

Tennessee Onc., PLLC - SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Onc., PLLC - SCRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.